+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Assessment of pulmonary arterial hypertension and vascular resistance by measurements of the pulmonary arterial flow velocity curve in the absence of a measurable tricuspid regurgitant velocity in childhood congenital heart disease



Assessment of pulmonary arterial hypertension and vascular resistance by measurements of the pulmonary arterial flow velocity curve in the absence of a measurable tricuspid regurgitant velocity in childhood congenital heart disease



Pediatric Cardiology 34(3): 646-655



This study aimed to determine mean pulmonary arterial pressure (PAPmean) and pulmonary vascular resistance (PVR) using transthoracic echocardiography (TTE) measurements of the pulmonary artery flow velocity curve in children with pulmonary arterial hypertension (PAH) and congenital heart disease when the tricuspid regurgitant velocity (TRV) is not sufficient. This study enrolled 29 congenital heart disease cases with pulmonary arterial hypertension and 40 healthy subjects followed at our center. The mean age was 66.9 ± 77.9 months in the patient group and 76.3 ± 62.1 months in the control group. A positive correlation was found between TRV and systolic pulmonary arterial pressure (r = 0.394, p = 0.035, 95% confidence interval [CI] = 0.032-0.665), whereas a negative correlation was found between corrected acceleration time (AcTc) and PAPmean (r = -0.559, p = 0.002, 95% CI = -0.768 to -0.242). Furthermore, a negative correlation was found between parameters TRV and AcTc (r = -0.383, p = 0.001, 95% CI = -0.657 to -0.019). Based on the cutoff criterion of 124 ms for AcTc, sensitivity was found to be 79.3% and specificity to be 77.5% in distinguishing between the PAH patients and the healthy control patients (receiver operating characteristic [ROC] area under the curve [AUC] = 0.804, 95% CI = 0.691-0.890, p < 0.0001). The sensitivity and specificity of the concomitant use of AcTc and/or TRV were found to be 90 and 73%, respectively, in distinguishing between the PAH patients and the the healthy control patients. The data obtained by TTE also can be appropriate for measuring PAPmean, PVR, and the vasoreactivity test and for determining the priority of implementing cardiac catheterization even if there is no measurable TRV value.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036610524

Download citation: RISBibTeXText

PMID: 23052666

DOI: 10.1007/s00246-012-0520-4


Related references

Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. American Heart Journal 162(3): 562-568, 2011

Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension. American Journal of Hematology 85(10): 741-745, 2010

Treatment responsiveness in pulmonary arterial hypertension--preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology 153(2): 219-221, 2012

Assessment Of Pulmonary Hypertension In Patients With Sickle Cell Disease With Tricuspid Regurgitant Jet Velocity Of Greater Than Or Equal To 2.5 M/Second On A Routine Echocardiogram. Chest 136(4): 61S-a1-61S-a2, 2009

Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension. Anadolu Kardiyoloji Dergisi 14(2): 196-198, 2015

Relationship between pulmonary arterial resistance and compliance among patients with pulmonary arterial hypertension and congenital heart disease. Journal of Thoracic and Cardiovascular Surgery 152(2): 507-513, 2018

The feasibility and clinical implication of tricuspid regurgitant velocity and pulmonary flow acceleration time evaluation for pulmonary pressure assessment during exercise stress echocardiography. European Heart Journal Cardiovascular Imaging 2019, 2019

Assessment of pulmonary arterial pressure by velocity-encoded cine magnetic resonance imaging in children with congenital heart disease. Circulation Journal 77(12): 3015-3022, 2014

Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. International Journal of Cardiovascular Imaging 16(6): 429-436, 2000

Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. International Journal of Cardiac Imaging 16(6): 429-436, 2001

Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatric Blood and Cancer 47(7): 907-913, 2006

Doppler-derived pulmonary regurgitation velocity is an index of pulmonary vascular resistance in children with congenital heart disease. Journal of Investigative Medicine 46(1): 136A, 1998

Doppler-derived pulmonary regurgitation velocity is a non-invasive index of pulmonary vascular resistance in children with congenital heart disease. Journal of the American College of Cardiology 31(2 SUPPL A): 467A, 1998

Non-invasive estimation of pulmonary vascular resistance in patients of pulmonary hypertension in congenital heart disease with unobstructed pulmonary flow. Annals of Pediatric Cardiology 7(2): 92-97, 2014

Management of pulmonary arterial hypertension associated with congenital heart disease with specific pulmonary arterial hypertension vasoactive drugs combined with transcatheter closure strategy:a case report. Zhonghua Xin Xue Guan Bing Za Zhi 42(11): 963-964, 2015